FDA Proposes Nicotine Cap on Cigarettes
Analysis based on 6 articles · First reported Jan 15, 2025 · Last updated Jan 15, 2025
The United States — Food and Drug Administration's proposal to cap nicotine content in cigarettes could significantly impact tobacco companies like British American Tobacco — Reynolds American and Altria, potentially leading to product reformulations and legal challenges. While the proposal aims to improve public health, its uncertain future under the Donald Trump administration and anticipated lawsuits create market volatility for the tobacco industry.
The United States — Food and Drug Administration has released a proposal to cap nicotine content in cigarettes, aiming to make them less addictive and reduce smoking-related deaths. This initiative, a long-standing goal for antismoking advocates, faces significant hurdles. It was introduced in the final days of Joe Biden's term, making its enactment uncertain under the incoming Donald Trump administration. Donald Trump's health secretary nominee, Robert F. Kennedy Jr., has not clearly stated his position on tobacco regulation. Furthermore, major tobacco companies such as British American Tobacco — Reynolds American and Altria are expected to challenge the rule in court, which would likely delay its implementation. The United States — Food and Drug Administration projects that reducing nicotine could help nearly 13 million smokers quit and prevent 48 million young people from starting. The proposal applies to cigarettes, cigars, and pipe tobacco but excludes e-cigarettes. The United States — Food and Drug Administration has previously authorized low-nicotine cigarettes and sponsored studies supporting their effectiveness in helping smokers quit.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard